Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.53
-$0.01-1.13%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -33.42% | 0.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.00% | -8.06% | |||
| Operating Income | 20.00% | 8.06% | |||
| Income Before Tax | 23.41% | 5.12% | |||
| Income Tax Expenses | -21.21% | 13.79% | |||
| Earnings from Continuing Operations | 23.41% | 5.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.41% | 5.10% | |||
| EBIT | 20.00% | 8.06% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 59.28% | 19.74% | |||
| Normalized Basic EPS | 59.27% | 19.77% | |||
| EPS Diluted | 59.28% | 19.74% | |||
| Normalized Diluted EPS | 59.27% | 19.77% | |||
| Average Basic Shares Outstanding | 88.08% | 18.24% | |||
| Average Diluted Shares Outstanding | 88.08% | 18.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||